Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/10095
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialBiotechnologyen_US
dc.date.accessioned2013-07-25T06:46:50Z-
dc.date.available2013-07-25T06:46:50Z-
dc.date.issued2013-07-25-
dc.identifier.urihttp://hdl.handle.net/10603/10095-
dc.description.abstractLymphatic filariasis (LF) is a major cause of acute and chronic morbidity affecting humans in tropical and subtropical areas of Asia, Africa, the Western Pacific, and some parts of the Americas. India accounts for a significant number of people suffering from parasitic infection. As part of the WHO sponsored Filarial Genome Project, many novel genes of W.bancrofti and B.malayi important for their diagnostic, prophylactic, chemotherapeutic potential and other genes involved in immune evasion and parasite survival mechanisms have been identified from various stages of the parasite life cycle. WHO has highlighted the importance of developing diagnostic assays, as a surveillance and measure to eliminate Lymphatic Filariasisand#8223;. Presently, problems in the immuno-diagnosis are the specificity to detect brugian and bancroftian parasites, stability of diagnostic lines, cost of assays, time and manpower associated with use of ELISA kit and PCR etc.,. These affect their application for disease assessment in endemic area. Two monoclonal antibodies namely 1F6H3 (IgG2a) and 2E12E3 (IgM) with better sensitivity were selected for validating capture ELISA. Sandwich ELISA was developed with SXP monoclonals as capture antibody and rabbit anti-SXP-1 polyclonal as detection antibody and validated against recombinant as well as native microfilaria antigen. The efficiency of sandwich ELISA was analyzed with MF positive samples and used NEN as control. The evaluated results of sandwich assay showed 100% sensitivity in the data obtained from experimental test groups. Results showed that the MF groups carried significantly higher antigen units (p lt 0.0001) compared to endemic normal, chronic pathology and non endemic normal groups. The MF group had the 100% antigen positive reactivity (0.769 ± 0.14) while EN and CP groups showed the 16.66 % (0.259 ± 0.084) and 0 % (0.271 ± 0.038) respectively.en_US
dc.format.extentxxvi, 178p.en_US
dc.languageEnglishen_US
dc.relationNo. of references 197en_US
dc.rightsuniversityen_US
dc.titleEnhancing the efficacy of diagnostic candidate WbSXP-1 and development of antigen based immune- diagnostic prototype for human lymphatic filariasisen_US
dc.creator.researcherPandey, Viveken_US
dc.subject.keywordLymphatic filariasisen_US
dc.subject.keywordImmune-diagnostic-
dc.subject.keywordAntigen-
dc.subject.keywordBrugian-
dc.subject.keywordBancroftian-
dc.description.noteAppendices p. 154-155, References p. 156-176, List of publications p.177en_US
dc.contributor.guideKaliraj Pen_US
dc.publisher.placeChennaien_US
dc.publisher.universityAnna Universityen_US
dc.publisher.institutionFaculty of Technologyen_US
dc.date.registeredn.d.en_US
dc.date.completed01/02/2010en_US
dc.date.awarded07/09/2011en_US
dc.format.dimensions23.5 cm x 15 cmen_US
dc.format.accompanyingmaterialNoneen_US
dc.source.universityUniversityen_US
dc.type.degreePh.D.en_US
Appears in Departments:Faculty of Technology

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File32.26 kBAdobe PDFView/Open
02_certificates.pdf825.01 kBAdobe PDFView/Open
03_abstract.pdf35.54 kBAdobe PDFView/Open
04_acknowledgement.pdf15.47 kBAdobe PDFView/Open
05_contents.pdf93.43 kBAdobe PDFView/Open
06_chapter 1.pdf562.19 kBAdobe PDFView/Open
07_chapter 2.pdf210.72 kBAdobe PDFView/Open
08_chapter 3.pdf1.83 MBAdobe PDFView/Open
09_chapter 4.pdf99.13 kBAdobe PDFView/Open
10_chapter 5.pdf21.28 kBAdobe PDFView/Open
11_appendices 1 and 2.pdf100.58 kBAdobe PDFView/Open
12_references.pdf168.15 kBAdobe PDFView/Open
13_publications.pdf39.94 kBAdobe PDFView/Open
14_vitae.pdf13.12 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: